
GenomicMD Launches Integrated Risk Assessment for Coronary Artery Disease to Enhance Cardiovascular Precision Medicine
Innovative Genomic Lab-Developed Test Analyzes Millions of Variants to Identify up to 30x More At-Risk Patients Than Traditional Genetic Testing CHICAGO, IL, UNITED STATES, October 3, 2025 /EINPresswire.com/ -- GenomicMD, a pioneering CLIA/ …